A significant advance in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer suppressor protein is frequently disabled in many forms of tumors, causing https://get-social-now.com/story7422816/mini-antibodies-reactivate-p53-a-new-approach-for-cancer-treatment